Beam Therapeutics

Youtube Subscribe

Open: 30.14 Close: 28.59 Change: -1.55

Don't invest in Beam Therapeutics before reading this automated analysis produce by an AI.

The game is changing. There is a new strategy to evaluate Beam Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Beam Therapeutics are: Beam, Therapeutics, company, Inc, NASDAQBEAM, announce, right, …

Concept Map

Semantic Network

Stock Summary

Beam Therapeutics generated $20.12 million in revenue for the quarter. Beam Therapies generated $21.5 billion in revenue in the first quarter..

Today's Summary

Beam Therapeutics (BEAM) has 13.826M shares short, which is 21.51% of float and 8.12 times average daily trading volume. The company is laying off about 100 employees and rejigging its pipeline priorities to save cash. The hematology targets sickle cell disease and is expected to be less risky than ‘simple” CRISpr-Cas9 therapies. Textress app offers Kerrare fellowshipLess Recent habitsAnderson Lit

Today's News

Beam Therapeutics Inc. (NASDAQ:BEAM) announced that Eli Lilly and Company has agreed to acquire certain rights under Beams collaboration and license agreement with Verve Therapeutic Inc., including the companies opt-in rights to Verves base editing programs for cardiovascular disease. Beam Therapeutics (BEAM) has 13.826M shares short, which is 21.51% of float and 8.12 times average daily trading volume. The company is laying off about 100 employees and rejigging its pipeline priorities to save cash, citing a “challenging market environment” Beam Therapeutics ( NASDAQ:BEAM – Get Free Report ) last announced its quarterly earnings data on Wednesday, November 8th. The company had a negative return on equity of 40.66% and a negative net margin. Beam Therapeutics is at an earlier stage than CRISPR Therapeuticss, with its manufacturing facilities expected to start only in late 2023. The hematology targets sickle cell disease (BEAM-101 treatment) and is expected by the company to be less risky than ‘simple” CRISpr-Cas9 therapies.

Stock Profile

" Russell Investments Group Ltd. increases stake in Beam Therapeutics; analysts provide mixed ratings and projections - best stocks. Beam Therapies generated $20.12 million in revenue for the quarter. Beam Therapeutics Inc. (US) job application for vp, business development at beam therapeutics. (NASDAQ:BEAM) Job Application for VP, Business Development at Beam Theraputics apply for this job. Beam Therapedutics has an analyst consensus of Moderate Buy, with a price target consensus of $49. Beam Therapeuticss stock price per share is $23.50 today (as of Aug 23, 2023) Beam Therapedutics stock market cap is $1.86B. If you had invested in Beam Theraputics stock at $18.75 your return over the last 3 years would have been 25.33%."

Keywords

How much time have you spent trying to decide whether investing in Beam Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Beam Therapeutics are: Beam, Therapeutics, company, Inc, NASDAQBEAM, announce, right, and the most common words in the summary are: therapeutic, beam, stock, company, news, inc, report, . One of the sentences in the summary was: Textress app offers Kerrare fellowshipLess Recent habitsAnderson Lit. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #beam #stock #company #news #inc #report.

Read more →

Youtube Subscribe

---